Fig. 6From: Biochemical and biophysical characterization of cell-free synthesized Rift Valley fever virus nucleoprotein capsids enables in vitro screening to identify novel antiviralsCyclic peptides representing RVFV N- and C-terminus inhibit the assembly of IOAS into HOFS. Cyclic peptides, representing different residues within RVFV NP, at various concentrations (H, High = 20 μM; M, Medium = 2 μM; L, Low = 0.2 μM) were diluted in 1 % DMSO and incubated in the CFPS assay. To control for the effect of the cyclic peptides on protein synthesis, eGFP was cotranslated in the presence of the various compoundsBack to article page